NCT01750905View on ClinicalTrials.gov

Safety Study of Chimeric Natriuretic Peptide(CD-NP) in Stable LVAD Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

August 31, 2016

Conditions

Left Ventricular Insufficiency

Interventions

DRUG

CD-NP

CD-NP 5 ug/kg subcutaneous injection (SQ)

DRUG

Placebo

Vehicle (D5W) SQ

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER